Staff Contact: Daniel Landon
The U.S. Department of Health and Human Services proposed to withdraw a Nov. 27, 2020, Trump administration rule on Medicare drug pricing. The original rule would have tied Medicare payment for drugs administered in physician offices to lower amounts paid for those drugs in various foreign countries. It was paused by several federal courts for procedural flaws and again further departmental review. The Biden administration is soliciting public comments on withdrawing the original rule and specified that it may issue its own proposal for curbing Medicare drug costs.